A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

PHASE2CompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

July 15, 2022

Conditions
Hyperlipidaemia
Interventions
DRUG

AZD8233

PCSK9-targeted ASO for the reduction of circulating levels of LDL-C.

DRUG

Placebo

Placebo solution

Trial Locations (66)

2400

Research Site, København NV

2650

Research Site, Hvidovre

2730

Research Site, Herlev

4000

Research Site, Roskilde

4032

Research Site, Debrecen

5600

Research Site, Békéscsaba

5700

Research Site, Svendborg

5900

Research Site, Orosháza

7400

Research Site, Herning

7501

Research Site, Trebišov

8200

Research Site, Aarhus N

8230

Research Site, Balatonfüred

8800

Research Site, Viborg

12553

Research Site, New Windsor

15006

Research Site, A Coruña

15405

Research Site, Ferrol

15706

Research Site, Santiago de Compostela

23435

Research Site, Suffolk

27408

Research Site, Greensboro

29464

Research Site, Mt. Pleasant

32216

Research Site, Jacksonville

33024

Research Site, Pembroke Pines

34452

Research Site, Inverness

35801

Research Site, Huntsville

41009

Research Site, Seville

41014

Research Site, Seville

44224

Research Site, Stow

45219

Research Site, Cincinnati

45246

Research Site, Cincinnati

46260

Research Site, Indianapolis

50009

Research Site, Zaragoza

58104

Research Site, Fargo

83646

Research Site, Meridian

91303

Research Site, Canoga Park

95648

Research Site, Lincoln

256 01

Research Site, Benešov

250 01

Research Site, Brandýs nad Labem

603 00

Research Site, Brno

551 01

Research Site, Jaroměř

460 01

Research Site, Liberec

440 01

Research Site, Louny

700 30

Research Site, Ostrava-Dubina

261 01

Research Site, Příbram

415 01

Research Site, Teplice

686 01

Research Site, Uherské Hradiště

1105 AZ

Research Site, Amsterdam

7009 BL

Research Site, Doetinchem

6716 RP

Research Site, Ede

2803 HH

Research Site, Gouda

3844 DG

Research Site, Harderwijk

3045 PM

Research Site, Rotterdam

85-079

Research Site, Bydgoszcz

32-500

Research Site, Chrzanów

30-082

Research Site, Krakow

91-002

Research Site, Lodz

24-100

Research Site, Puławy

41-710

Research Site, Ruda Śląska

43-100

Research Site, Tychy

33-122

Research Site, Wierzchosławice

831 03

Research Site, Bratislava

977 01

Research Site, Brezno

984 01

Research Site, Lučenec

080 01

Research Site, Prešov

048 01

Research Site, Rožňava

08901

Research Site, Svidník

08907

Research Site, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY